(19)
(11) EP 3 606 540 A1

(12)

(43) Date of publication:
12.02.2020 Bulletin 2020/07

(21) Application number: 18781756.4

(22) Date of filing: 09.04.2018
(51) International Patent Classification (IPC): 
A61K 35/28(2015.01)
C07K 16/46(2006.01)
A61P 35/00(2006.01)
A61P 37/06(2006.01)
 C12N 5/0775(2010.01)
A61K 45/08(2006.01)
A61P 35/02(2006.01)
(86) International application number:
PCT/AU2018/050321
(87) International publication number:
WO 2018/184074 (11.10.2018 Gazette 2018/41)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.04.2017 AU 2017901273

(71) Applicant: Cynata Therapeutics Limited
Carlton VIC 3053 (AU)

(72) Inventors:
  • KELLY, Kilian
    Carlton Victoria 3053 (AU)
  • SLUKVIN, Igor
    Verona WI 53593 (US)

(74) Representative: Calysta NV 
Lambroekstraat 5a
1831 Diegem
1831 Diegem (BE)

   


(54) METHOD FOR TREATING A SIDE EFFECT OF CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY